IM-101

· ImmunAbs Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IM-101, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis [Phase 1, Phase 2]

See pricing